In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010454 | ent-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1S,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010455 | 20-A4-NeuroP | (4Z,7Z,10Z)-12-((1R,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010456 | ent-13,20-diepi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1R,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010457 | 13-epi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1S,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010458 | ent-20-epi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1S,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010459 | 4-epi-4-J4-NeuroP | (R,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010460 | ent-7-epi-4-J4-NeuroP | (R,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010461 | 4,7-diepi-4-J4-NeuroP | (R,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010462 | ent-4-J4-NeuroP | (R,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010463 | 4-J4-NeuroP | (S,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010464 | ent-4,7-diepi-4-J4-NeuroP | (S,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010465 | 7-epi-4-J4-NeuroP | (S,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010466 | ent-4-epi-4-J4-NeuroP | (S,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010467 | 7-epi-7-J4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010468 | ent-10-epi-7-J4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010469 | 7,10-diepi-7-J4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010470 | ent-7-J4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010471 | 7-J4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010472 | ent-7,10-diepi-7-J4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010473 | 10-epi-7-J4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010474 | ent-7-epi-7-J4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010475 | 10-epi-10-J4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010476 | ent-13-epi-10-J4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010477 | 10,13-diepi-10-J4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010478 | ent-10-J4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010479 | 10-J4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010480 | ent-10,13-diepi-10-J4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010481 | 13-epi-10-J4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010482 | ent-10-epi-10-J4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010483 | 11-epi-11-J4-NeuroP | 3-((1S,5S)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010484 | ent-4-epi-11-J4-NeuroP | 3-((1S,5R)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010485 | 4,11-diepi-11-J4-NeuroP | 3-((1R,5S)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010486 | ent-11-J4-NeuroP | 3-((1R,5R)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010487 | 11-J4-NeuroP | 3-((1S,5S)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010488 | ent-4,11-diepi-11-J4-NeuroP | 3-((1S,5R)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010489 | 4-epi-11-J4-NeuroP | 3-((1R,5S)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010490 | ent-11-epi-11-J4-NeuroP | 3-((1R,5R)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010491 | 13-epi-13-J4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010492 | ent-16-epi-13-J4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010493 | 13,16-diepi-13-J4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010494 | ent-13-J4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010495 | 13-J4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010496 | ent-13,16-diepi-13-J4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010497 | 16-epi-13-J4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010498 | ent-13-epi-13-J4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010499 | 14-epi-14-J4-NeuroP | (Z)-6-((1S,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010500 | ent-7-epi-14-J4-NeuroP | (Z)-6-((1S,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010501 | 7,14-diepi-14-J4-NeuroP | (Z)-6-((1R,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010502 | ent-14-J4-NeuroP | (Z)-6-((1R,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010503 | 14-J4-NeuroP | (Z)-6-((1S,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |